The DOI matches its Crossref record; 271 of the 271 references it cites were found in a registry or an index.
HIV and Tuberculosis: a Deadly Human Syndemic
Open accessAbstract
SUMMARY: A syndemic is defined as the convergence of two or more diseases that act synergistically to magnify the burden of disease. The intersection and syndemic interaction between the human immunodeficiency virus (HIV) and tuberculosis (TB) epidemics have had deadly consequences around the world. Without adequate control of the TB-HIV syndemic, the long-term TB elimination target set for 2050 will not be reached. There is an urgent need for additional resources and novel approaches for the diagnosis, treatment, and prevention of both HIV and TB. Moreover, multidisciplinary approaches that consider HIV and TB together, rather than as separate problems and diseases, will be necessary to prevent further worsening of the HIV-TB syndemic. This review examines current knowledge of the state and impact of the HIV-TB syndemic and reviews the epidemiological, clinical, cellular, and molecular interactions between HIV and TB.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Originally focused on vulnerable communities in high-income countries (HICs) [ 1 ], more recently, a syndemics approach has been applied in low- and middle-income countries (LMICs) [ 13–15 ].”
From Syndemic contexts: findings from a review of research on non-communicable diseases and interviews with experts (2021) · cites this paper as [14]
In the citing paper
“Studies show that HIV co-infection, which increases the risk of latent TB reactivation 20-fold, is the most powerful known risk factor for the progression of Mycobacterium tuberculosis infection to an active disease [16,17].”
From Treatment success rate of tuberculosis patients in Dabat, northwest Ethiopia (2014) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents
(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-12_part_2-199806151-00003 · Cited by 5,209
The Growing Burden of Tuberculosis: Global Trends and Interactions With the HIV Epidemic
Corbett, E. L., Watt, C. J., Walker, N., Maher, D., Williams, B. G., Raviglione, M. C., & Dye, C. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.9.1009 · Cited by 2,553 · cited 2×
“The confluence of the two epidemics has hit hardest in sub-Saharan Africa, which constituted 79% of all cases of incident TB in persons with HIV infection in 2007 (62, 263).”
BackgroundAn essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.
Flynn, J. L., Chan, J., Triebold, K. J., Dalton, D. K., Stewart, T. A., & Bloom, B. R. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2249 · Cited by 2,465 · cited 19×
“Ironically, the fifth subject, for whom the frequency of M. tuberculosis antigen-responsive IFN- -producing cells did not decline, developed active TB, which was accompanied by an increased frequency of M. tuberculosis antigenresponsive IFN- -producing CD4 memory cells.”
ResultInfluentialRapid Molecular Detection of Tuberculosis and Rifampin Resistance
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907847 · Cited by 2,309 · cited 4×
“In South African study populations with HIV prevalence rates of 71 to 76%, Xpert MTB/RIF testing of three sputum samples (one direct and two concentrated) has a sensitivity of greater than 95% for all culture-positive TB cases, with 99 to 100% sensitivity for smear-positive, culture-positive TB; 87 to 90% sensitivity…”
BackgroundMethodInfluentialAn inducible transcription factor activates expression of human immunodeficiency virus in T cells
Nabel, G., & Baltimore, D. (1987) · Nature · doi:10.1038/326711a0 · Cited by 2,041 · cited 1×
“TLR2, TLR4, NOD2, and TNF all signal through the host transcription factor NF- B (179), which directly activates the transcription of HIV (79, 201, 205).”
BackgroundDisseminated tuberculosis in interferon gamma gene-disrupted mice.
Cooper, A. M., Dalton, D. K., Stewart, T. A., Griffin, J. P., Russell, D. G., & Orme, I. M. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2243 · Cited by 1,986 · cited 19×
“Ironically, the fifth subject, for whom the frequency of M. tuberculosis antigen-responsive IFN- -producing cells did not decline, developed active TB, which was accompanied by an increased frequency of M. tuberculosis antigenresponsive IFN- -producing CD4 memory cells.”
ResultInfluentialGandhi, N. R., Moll, A., Sturm, A. W., Pawinski, R., Govender, T., Lalloo, U., Zeller, K., Andrews, J., & Friedland, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69573-1 · Cited by 1,732 · cited 28×
“The use of NVP with rifampin was associated with higher rates of virologic failure starting at 6 months after the initiation of treatment in a South African prospective cohort study (29).”
BackgroundInfluentialOsborn, L., Kunkel, S., & Nabel, G. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2336 · Cited by 1,621 · cited 1×
“TLR2, TLR4, NOD2, and TNF all signal through the host transcription factor NF- B (179), which directly activates the transcription of HIV (79, 201, 205).”
BackgroundSelwyn, P. A., Hartel, D., Lewis, V. A., Schoenbaum, E. E., Vermund, S. H., Klein, R. S., Walker, A. T., & Friedland, G. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903023200901 · Cited by 1,574 · cited 2×
“A prospective study of injection drug users (IDUs) enrolled in a methadone maintenance program in New York City found that active TB developed in 7 of 49 HIV-infected subjects with a prior positive purified protein derivative (PPD) test and in none of 62 HIV-uninfected subjects with a prior positive PPD test (227).”
BackgroundTuberculosis in Patients with Human Immunodeficiency Virus Infection
Havlir, D. V., & Barnes, P. F. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902043400507 · Cited by 1,461 · cited 6×
“Evidence that HIV serves as a driver of TB at the population level has been noted by multiple epidemiological studies (15, 20).”
BackgroundInfluential
Research works printed but not linked: 4
- CDC. 1991. Epidemiologic notes and reports of nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons—Florida and New York, 1988-1991. MMWR Morb. Mortal. Wkly. Rep. 40:585–591.
- Desalu O. . 2009. Impact of immunosuppression on radiographic features of HIV related pulmonary tuberculosis among Nigerians. Turk. Thorac. J. 11:112–116.
- 10.1172/JCI200317533 · doi:10.1172/jci200317533 · Paper page
- Meintjes G. . 2009. Randomized placebo-controlled trial of prednisone for the TB immune reconstitution inflammatory syndrome, abstr. 34. Abstr. Conf. Retrovir. Oppor. Infect. 2009, Montreal, Canada.
Cited by
Infectious disease in an era of global change
Baker, R. E., Mahmud, A. S., Miller, I. F., Rajeev, M., Rasambainarivo, F., Rice, B. L., Takahashi, S., Tatem, A. J., Wagner, C. E., Wang, L.-F., et al. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00639-z · Cited by 2,059
Immune evasion and provocation by Mycobacterium tuberculosis
Chandra, P., Grigsby, S. J., & Philips, J. A. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00763-4 · Cited by 614
Ecology and evolution of Mycobacterium tuberculosis
Gagneux, S. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2018.8 · Cited by 599
Host Genotype-Specific Therapies Can Optimize the Inflammatory Response to Mycobacterial Infections
Tobin, D. M., Roca, F. J., Oh, S. F., McFarland, R., Vickery, T. W., Ray, J. P., Ko, D. C., Zou, Y., Bang, N. D., Chau, T. T. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.023 · Cited by 580
“Similarly, a range of nongenetic immunosuppression—Human ImmunodeficiencyVirus (HIV) infection, TNF-blocking and glucocorticoid treatments—increases susceptibility to TB (Kwan and Ernst, 2011; Lawn and Zumla, 2011).”
BackgroundThe immunological life cycle of tuberculosis
Ernst, J. D. (2012) · Nature Reviews Immunology · doi:10.1038/nri3259 · Cited by 577
Self-citation
Metadata
- Authors
- Kwan, C. K., & Ernst, J. D.
- Affiliations
- New York University (US)
- ORCID
- Ernst, Joel D.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2011-04
- Volume
- 24
- Issue
- 2
- Pages
- 351-376
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- PMC
- PMC3122491
- OpenAlex
- W2137617609
- Cited by
- 720
- References
- 271
- Citations by year
- 2026: 31 · 2025: 42 · 2024: 40 · 2023: 64 · 2022: 55 · 2021: 51 · 2020: 66 · 2019: 43 · 2018: 59 · 2017: 53 · 2016: 47 · 2015: 45 · 2014: 40 · 2013: 34 · 2012: 46
- FWCI
- 4.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Clinical Microbiology Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R01AI090928, R01AI084041, R01AI051242)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › HIV, TB, and STIs Epidemiology
- Keywords
- HIV, tuberculosis, syndemic, HIV/TB coinfection, tuberculosis elimination, disease burden, tuberculosis diagnosis, tuberculosis treatment, tuberculosis prevention, multidisciplinary approach
- MeSH terms
- Communicable Disease Control, Humans, Tuberculosis, HIV Infections, Comorbidity, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: HIV and Tuberculosis: a Deadly Human Syndemic. https://app.cochat.ai/papers/10.1128/cmr.00042-10
- The paper
- Kwan, C. K., & Ernst, J. D. (2011). HIV and Tuberculosis: a Deadly Human Syndemic. Clinical Microbiology Reviews. https://doi.org/10.1128/cmr.00042-10
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.